Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cited by (1,048)

Items 401–500 of 1,048

1. Current status of potential therapeutic candidates for the COVID-19 crisis
   Jiancheng Zhang, Bing Xie, Kenji Hashimoto · 2020 · Brain Behavior and Immunity
2. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome
   Maxwell I. Zimmerman, Justin R. Porter, Michael D. Ward, Sukrit Singh, Neha Vithani, Artur Meller, Upasana L. Mallimadugula, Catherine E. Kuhn, Jonathan H. Borowsky, Rafal Wiewiora et al. · 2021 · Nature Chemistry
3. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
   Jun Zhang, Tianshu Xiao, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, Krishna Anand, Pei Tong, Avneesh Kumar Gautam, Megan L. Mayer et al. · 2021 · Science
4. On the origin and evolution of SARS-CoV-2
   Singh, Devika, Yi, Soojin V. · 2021 · Experimental & Molecular Medicine
5. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody
   Wanchao Yin, Youwei Xu, Peiyu Xu, Xiaodan Cao, Canrong Wu, Chunyin Gu, Xinheng He, Xiaoxi Wang, Sijie Huang, Qingning Yuan et al. · 2022 · Science
6. Progress and Prospects on Vaccine Development against SARS-CoV-2
   Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng, Quanming Zou · 2020 · Vaccines
7. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study
   Priya Shree, Priyanka Mishra, Chandrabose Selvaraj, Sanjeev Kumar Singh, Radha Chaube, Neha Garg, Yamini Bhusan Tripathi · 2020 · Journal of Biomolecular Structure and Dynamics
8. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
   Dhanusha Yesudhas, Ambuj Srivastava, M. Michael Gromiha · 2020 · Infection
9. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
   Mirco Friedrich, Paola Neri, Niklas Kehl, Julius Michel, Simon Steiger, Michael Kilian, Noémie Leblay, Ranjan Maity, Roman Sankowski, Holly Lee et al. · 2023 · Cancer Cell
10. Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
    Emily Rebecca Adams, Mark Andrew Ainsworth, Rekha Anand, Monique Ingrid Andersson, Kathryn Auckland, John Kenneth Baillie, Eleanor J. Barnes, Sally Beer, John I. Bell, Tamsin Berry et al. · 2020 · Wellcome Open Research
11. Recombinant protein vaccines, a proven approach against coronavirus pandemics
    Jeroen B. K. Pollet, Wen‐Hsiang Chen, Ulrich Strych · 2021 · Advanced Drug Delivery Reviews
12. COVID–19-associated coagulopathy: An exploration of mechanisms
    Meaghan E. Colling, Yogendra M. Kanthi · 2020 · Vascular Medicine
13. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
    Cheol-Min Kim, Dong-Kyun Ryu, Jihun Lee, Young‐Il Kim, Ji Min Seo, Yeon‐Gil Kim, Jae-Hee Jeong, Minsoo Kim, Jong-In Kim, Pankyeom Kim et al. · 2021 · Nature Communications
14. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
    Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Rong Li, Valentijn Vergote, Laura Seldeslachts, Johan Van Weyenbergh, Carolien De Keyzer, Lindsey Bervoets, Sapna Sharma et al. · 2020 · Nature Communications
15. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
    Zhou, Daming, Duyvesteyn, Helen M. E., Chen, Cheng-Pin, Huang, Chung-Guei, Chen, Ting-Hua, Shih, Shin-Ru, Lin, Yi-Chun, Cheng, Chien-Yu, Cheng, Shu-Hsing, Huang, Yhu-Chering et al. · 2020 · Nature Structural & Molecular Biology
16. The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
    Pedro Morais, Hironori Adachi, Yi‐Tao Yu · 2021 · Frontiers in Cell and Developmental Biology
17. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
    Amanat, Fatima, Thapa, Mahima, Lei, Tinting, Ahmed, Shaza M. Sayed, Adelsberg, Daniel C., Carreño, Juan Manuel, Strohmeier, Shirin, Schmitz, Aaron J., Zafar, Sarah, Zhou, Julian Q. et al. · 2021 · Cell
18. Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
    Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, Laura E. Rosen, Ha V. Dang, Anna De Marco, Nicholas Franko, Sasha W. Tilles, Jennifer K. Logue et al. · 2021 · Science
19. Circular RNA vaccine in disease prevention and treatment
    Dun Niu, Yaran Wu, Jiqin Lian · 2023 · Signal Transduction and Targeted Therapy
20. Monoclonal Antibodies for Prevention and Treatment of COVID-19
    Mary Marovich, John R. Mascola, Myron S. Cohen · 2020 · JAMA
21. SARS-CoV-2: from its discovery to genome structure, transcription, and replication
    Ayslan Castro Brant, Wei Tian, Vladimır Majerčiak, Wei Yang, Zhi‐Ming Zheng · 2021 · Cell & Bioscience
22. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits
    Shitao Rao, Alexandria Lau, Hon‐Cheong So · 2020 · Diabetes Care
23. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
    Lisa H. Tostanoski, Frank Wegmann, Amanda Jezek Martinot, Carolin Loos, Katherine McMahan, Noe B. Mercado, Jingyou Yu, Chi Ngai Chan, Stephen Bondoc, Carly E. Starke et al. · 2020 · Nature Medicine
24. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
    Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa, Mika Hirose, Emi E. Nakayama, Songling Li, Miwa Sasai, Tatsuya Suzuki, Asa Tada, Akemi Arakawa et al. · 2021 · Cell
25. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain
    Zhengqian Li, Taotao Liu, Ning Yang, Dengyang Han, Xinning Mi, Yue Li, Kaixi Liu, Alain Vuylsteke, Hong‐Bing Xiang, Xiangyang Guo · 2020 · Frontiers of Medicine
26. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
    Ge Song, Wanting He, Sean Callaghan, Fabio Anzanello, Deli Huang, James Ricketts, Jonathan L. Torres, Nathan Beutler, Linghang Peng, Sirena Vargas et al. · 2021 · Nature Communications
27. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
    Frauke Muecksch, Yiska Weisblum, Christopher O. Barnes, Fabian Schmidt, Dennis J. Schaefer-Babajew, Zijun Wang, Julio C. C. Lorenzi, Andrew I. Flyak, Andrew T. DeLaitsch, Kathryn E. Huey‐Tubman et al. · 2021 · Immunity
28. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
    Salma Sheikh‐Mohamed, Baweleta Isho, Gary Y. C. Chao, Michelle Zuo, Carmit Cohen, Yaniv Lustig, George Ronald Nahass, Rachel E.A. Salomon, Grace Blacker, Mahya Fazel‐Zarandi et al. · 2022 · Mucosal Immunology
29. Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
    Zhenzhen Wang, Kristen D. Popowski, Dashuai Zhu, Blanca López de Juan Abad, Xianyun Wang, Mengrui Liu, Halle Lutz, Nicole De Naeyer, C. Todd DeMarco, Thomas N. Denny et al. · 2022 · Nature Biomedical Engineering
30. Architecture and self‐assembly of the SARS‐CoV ‐2 nucleocapsid protein
    Qiaozhen Ye, Alan M.V. West, Steve Silletti, Kevin D. Corbett · 2020 · Protein Science
31. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review
    Susmit Mhatre, Tishya Srivastava, Shivraj Vasantrao Naik, Vandana Bharat Patravale · 2020 · Phytomedicine
32. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
    Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, Adam K. Wheatley, Danijela Zukancic, Azizah Algarni, Hareth A. Al-Wassiti, Thomas Paul Davis, Colin William Pouton, Stephen John Kent et al. · 2021 · Acta Biomaterialia
33. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
    Bhawna Tomar, Hans‐Joachim Anders, Jyaysi Desai, Shrikant R. Mulay · 2020 · Cells
34. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
    Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, Enrique Roberto Argañaraz · 2020 · Frontiers in Immunology
35. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
    Guangyu Zhou, Qi Zhao · 2020 · International Journal of Biological Sciences
36. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
    Neeltje van Doremalen, Jyothi N. Purushotham, Jonathan E. Schulz, Myndi G. Holbrook, Trenton Bushmaker, Aaron Carmody, Julia Rebecca Port, Claude Kwe Yinda, Atsushi Okumura, Greg A. Saturday et al. · 2021 · Science Translational Medicine
37. Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
    Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., Pisani, A. · 2020 · European Journal of Neurology
38. Identification of Human Single-Domain Antibodies against SARS-CoV-2
    Yanling Wu, Cheng Li, Shuai Xia, Xiaolong Tian, Yu Kong, Zhi Wang, Chenjian Gu, Rong Zhang, Chao Tu, Youhua Xie et al. · 2020 · Cell Host & Microbe
39. Updated Approaches against SARS-CoV-2
    Haiou Li, Yunjiao Zhou, Meng Zhang, Haizhou Wang, Qiu Zhao, Jing Liu · 2020 · Antimicrobial Agents and Chemotherapy
40. Mask use during COVID-19: A risk adjusted strategy
    Jiao Wang, Lijun Pan, Song Tang, John S. Ji, Xiaoming Shi · 2020 · Environmental Pollution
41. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
    Elisa Benetti, Rossella Tita, Ottavia Spiga, Andrea Ciolfi, Giovanni Birolo, Alessandro Bruselles, Gabriella Doddato, Annarita Giliberti, Caterina Marconi, Francesco Musacchia et al. · 2020 · European Journal of Human Genetics
42. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
    Mary Kathryn Bohn, Alexandra Hall, Lusia Sepiashvili, Benjamin Jung, Shannon Steele, Khosrow Adeli · 2020 · Physiology
43. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
    Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp A. Steininger, Katharina Marie Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong et al. · 2022 · Science Immunology
44. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
    Cheryl Yi‐Pin Lee, Raymond Tzer Pin Lin, Laurent Rénia, Lisa F. P. Ng · 2020 · Frontiers in Immunology
45. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
    Bok, Karin, Sitar, Sandra, Graham, Barney S., Mascola, John R. · 2021 · Immunity
46. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
    Saunders, Kevin O., Lee, Esther, Parks, Robert, Martinez, David R., Li, Dapeng, Chen, Haiyan, Edwards, Robert J., Gobeil, Sophie, Barr, Maggie, Mansouri, Katayoun et al. · 2021 · Nature
47. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
    Prasun K. Datta, Fengming Liu, Tracy Fischer, Jay Rappaport, Xuebin Qin · 2020 · Theranostics
48. The Role of Adipocytes and Adipocyte‐Like Cells in the Severity of COVID‐19 Infections
    Ilja L. Kruglikov, Philipp E. Scherer · 2020 · Obesity
49. Broad sarbecovirus neutralization by a human monoclonal antibody
    M. Alejandra Tortorici, Nadine Czudnochowski, Tyler N. Starr, Roberta Marzi, Alexandra C. Walls, Fabrizia Zatta, John E. Bowen, Stefano Jaconi, Julia di Iulio, Zhaoqian Wang et al. · 2021 · Nature
50. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
    Glasgow, Anum, Glasgow, Jeff, Limonta, Daniel, Solomon, Paige, Lui, Irene, Zhang, Yang, Nix, Matthew A., Rettko, Nicholas J., Zha, Shoshana, Yamin, Rachel et al. · 2020 · Proceedings of the National Academy of Sciences
51. One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device
    Liping Huang, Longfei Ding, Jun Zhou, Shuiliang Chen, Fang Chen, Chen Zhao, Yiyi Zhang, Wenjun Hu, Wenjun Hu, Jiansong Ji et al. · 2020 · Biosensors and Bioelectronics
52. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
    Rolando Cannalire, Carmen Cerchia, Andrea R. Beccari, Francesco Saverio Di Leva, Vincenzo Summa · 2020 · Journal of Medicinal Chemistry
53. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease
    Mingzhi Li, Pinggui Lei, Bingliang Zeng, Zongliang Li, Peng Cheng Yu, Bing Fan, Chuanhong Wang, Zicong Li, Jian Zhou, Shaobo Hu et al. · 2020 · Academic Radiology
54. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
    Naveen Vankadari · 2020 · International Journal of Antimicrobial Agents
55. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
    William N. Voss, Yixuan Jacob Hou, Nicole V. Johnson, George Delidakis, Jin Eyun Kim, Kamyab Javanmardi, Andrew P. Horton, Foteini Bartzoka, Chelsea Paresi, Yuri Tanno et al. · 2021 · Science
56. Charge-Transfer Resonance and Electromagnetic Enhancement Synergistically Enabling MXenes with Excellent SERS Sensitivity for SARS-CoV-2 S Protein Detection
    Yusi Peng, Chenglong Lin, Long Li, Masaki Tanemura, Mao Tang, Lili Yang, Jianjun Liu, Zhengren Huang, Zhiyuan Li, Xiaoying Luo et al. · 2021 · Nano-Micro Letters
57. SARS-CoV-2 spreads through cell-to-cell transmission
    Zeng, Cong, Evans, John P., King, Tiffany, Zheng, Yi-Min, Oltz, Eugene M., Whelan, Sean P. J., Saif, Linda J., Peeples, Mark E., Liu, Shan-Lu · 2022 · Proceedings of the National Academy of Sciences
58. SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
    Kuldeep Dhama, Shailesh Kumar Patel, Khan Sharun, Mamta Pathak, Ruchi Tiwari, Mohd. Iqbal Yatoo, Yashpal Singh Malik, Ranjit Sah, Ali Ahmed Rabaan, Parmod Kumar Panwar et al. · 2020 · Travel Medicine and Infectious Disease
59. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
    Qi Zhang, Catherine Zhengzheng Chen, Manju Swaroop, Miao Xu, Lihui Wang, Juhyung Lee, Amy Qiu Wang, Manisha Pradhan, Natalie R. Hagen, Lu Chen et al. · 2020 · Cell Discovery
60. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells
    Christoph Muus, Malte D. Luecken, Gökçen Eraslan, Avinash Waghray, Graham Heimberg, Lisa Sikkema, Yoshihiko Kobayashi, Eeshit Dhaval Vaishnav, Ayshwarya Subramanian, Christopher Smilie et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
61. An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
    Fuzhou Wang, Richard M. Kream, George B. Stefano · 2020 · Medical Science Monitor
62. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
    Ayal B. Gussow, Noam Auslander, Guilhem Faure, Yuri I. Wolf, Feng Zhang, Eugene V. Koonin · 2020 · Proceedings of the National Academy of Sciences
63. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors
    Manvendra Singh, Vikas Bansal, Cédric Feschotte · 2020 · Cell Reports
64. Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
    Mukhtar H. Ahmed, Arez Hassan · 2020 · SN Comprehensive Clinical Medicine
65. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field
    Beatrice Stefanie Ludwig, Horst Kessler, Susanne Kossatz, Ute Reuning · 2021 · Cancers
66. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
    Shuo Du, Yunlong Cao, Qinyu Zhu, Pin Yü, Feifei Qi, Guopeng Wang, Xiaoxia Du, Linlin Bao, Wei Deng, Huachen Zhu et al. · 2020 · Cell
67. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
    Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, Sergio Aguirre‐Sampieri, Alicia Sampieri, Luis A. Vaca · 2021 · Frontiers in Immunology
68. Structure of SARS-CoV-2 spike protein
    Jun Zhang, Tianshu Xiao, Yongfei Cai, Bing Chen · 2021 · Current Opinion in Virology
69. The immunology of COVID-19: is immune modulation an option for treatment?
    Jixin Zhong, Jungen Tang, Cong Ye, Lingli Dong · 2020 · The Lancet Rheumatology
70. Rapid SARS-CoV-2 Spike Protein Detection by Carbon Nanotube-Based Near-Infrared Nanosensors
    Rebecca L. Pinals, Francis Ledesma, Darwin Yang, Nicole Navarro, Sanghwa Jeong, John E. Pak, Lili Kuo, Yung‐Chun Chuang, Yu‐Wei Cheng, Hung-Yu Sun et al. · 2021 · Nano Letters
71. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
    Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, Pao-Yin Chiang, Shih-Han Ko, Feng-Yi Ke, Kang-Hao Liang, Tzung-Yang Hsieh, Han‐Chung Wu · 2022 · Journal of Biomedical Science
72. The clinical course and its correlated immune status in COVID-19 pneumonia
    Ruyuan He, Zilong Lu, Lin Zhang, Tao T. Fan, Rui Xiong, Xiaokang Shen, Haojie Feng, Heng Meng, Weichen Lin, Wenyang Jiang et al. · 2020 · Journal of Clinical Virology
73. Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen
    Sophie Mavrikou, Georgia Moschopoulou, Vasileios Tsekouras, Spyridon E. Kintzios · 2020 · Sensors
74. Could Vitamins Help in the Fight Against COVID-19?
    Jovic, Thomas H, Ali, Stephen R, Ibrahim, Nader, Jessop, Zita M, Tarassoli, Sam P, Dobbs, Thomas D, Holford, Patrick, Thornton, Catherine A, Whitaker, Iain S · 2020 · Nutrients
75. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
    Xiangyu Chen, Zhiwei Pan, Shuai Yue, Fei Yu, Junsong Zhang, Yang Yang, Ren Li, Bingfeng Liu, Xiaofan Yang, Leiqiong Gao et al. · 2020 · Signal Transduction and Targeted Therapy
76. Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
    Zhengnan Shen, Kiira M Ratia, Laura M. Cooper, Deyu Kong, Hyun Lee, Youngjin Kwon, Yangfeng Li, Saad Alqarni, Fei Huang, Oleksii Dubrovskyi et al. · 2021 · Journal of Medicinal Chemistry
77. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
    Elena Ciaglia, Carmine Vecchione, Annibale Alessandro Puca · 2020 · Frontiers in Pediatrics
78. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
    Afshin A. Divani, Sasan Andalib, Mario Di Napoli, Simona Lattanzi, Muhammad Shazam Hussain, José Biller, Louise D. McCullough, Mahmoud Reza Azarpazhooh, Alina Seletska, Stephan A. Mayer et al. · 2020 · Journal of Stroke and Cerebrovascular Diseases
79. Is the kidney a target of SARS-CoV-2?
    Miguel Angel Martínez-Rojas, Olynka Vega‐Vega, Norma Araceli Bobadilla · 2020 · American Journal of Physiology-Renal Physiology
80. Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
    Amanat Ali, Ranjit Vijayan · 2020 · Scientific Reports
81. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
    Guebre-Xabier, Mimi, Patel, Nita, Tian, Jing-Hui, Zhou, Bin, Maciejewski, Sonia, Lam, Kristal, Portnoff, Alyse D., Massare, Michael J., Frieman, Matthew B., Piedra, Pedro A. et al. · 2020 · Vaccine
82. Growth, detection, quantification, and inactivation of SARS-CoV-2
    James Brett Case, Adam L. Bailey, Arthur S. Kim, Rita E. Chen, Michael Diamond · 2020 · Virology
83. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
    Masae Iwasaki, Junichi Saito, Hailin Zhao, Atsuhiro Sakamoto, Kazuyoshi Hirota, Daqing Ma · 2020 · Inflammation
84. Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane
    Hyeonuk Woo, Sang‐Jun Park, Yeol Kyo Choi, Taeyong Park, Maham Tanveer, Yiwei Cao, Nathan R. Kern, Jumin Lee, Min Sun Yeom, Tristan Ian Croll et al. · 2020 · The Journal of Physical Chemistry B
85. How can nanotechnology help to combat COVID-19? Opportunities and urgent need
    Estefânia Vangelie Ramos Campos, Anderson do Espírito Santo Pereira, Jhones Luiz de Oliveira, Lucas Bragança Carvalho, Mariana Guilger‐Casagrande, Renata de Lima, Leonardo Fernandes Fraceto · 2020 · Journal of Nanobiotechnology
86. An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells
    Lamers, Mart M, van der Vaart, Jelte, Knoops, Kèvin, Riesebosch, Samra, Breugem, Tim I, Mykytyn, Anna Z, Beumer, Joep, Schipper, Debby, Bezstarosti, Karel, Koopman, Charlotte D et al. · 2021 · The EMBO Journal
87. Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management
    Ajeet Kumar Kaushik, Jaspreet Singh Dhau, Hardik Gohel, Yogendra Kumar Mishra, Babak Kateb, Nam‐Young Kim, Dharendra Yogi Goswami · 2020 · ACS Applied Bio Materials
88. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
    Yin-Feng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiang-Ping Li, Pingping Zhou, Xin-Chun Chen, Zhe Liu, Xiao Zhang et al. · 2021 · ACS Nano
89. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
    Yuanmei Zhu, Danwei Yu, Hongxia Yan, Huihui Chong, Yuxian He · 2020 · Journal of Virology
90. Accelerating antiviral drug discovery: lessons from COVID-19
    Annette von Delft, Matthew D. Hall, Ann D. Kwong, Lisa A. Purcell, Kumar Singh Saikatendu, Uli Schmitz, John A. Tallarico, Alpha A. Lee · 2023 · Nature Reviews Drug Discovery
91. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
    Massimo Imazio, Karin Klingel, Ingrid Kindermann, Antonio Luca Brucato, Francesco Giuseppe De Rosa, Yehuda Adler, Gaetano Maria De Ferrari · 2020 · Heart
92. Natural history of COVID-19 and current knowledge on treatment therapeutic options
    Wagner Gouvêa dos Santos · 2020 · Biomedicine & Pharmacotherapy
93. Vaccines for COVID-19
    John S. Tregoning, E S Brown, Hannah M. Cheeseman, Katie E. Flight, Sophie L. Higham, N-M Lemm, Benjamin F. Pierce, David C. Stirling, Ziyin Wang, Katrina M. Pollock · 2020 · Clinical & Experimental Immunology
94. Inhibitors of SARS-CoV‑2 Entry: Current and Future Opportunities
    Siyu Xiu, Alexej Dick, Han Ju, Sako Mirzaie, Fatemeh Abdi, Simon Cocklin, Peng Zhan, Xinyong Liu · 2020 · Journal of Medicinal Chemistry
95. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells
    Tapas Patra, Keith Meyer, Lizzie Geerling, Timothy Scott Isbell, Daniel Fredric Hoft, James D. Brien, Amelia K. Pinto, Ratna B. Ray, Ranjit Ray · 2020 · PLoS Pathogens
96. Pathogenesis and treatment of cytokine storm in COVID-19
    Mehmet Soy, Gökhan Keser, Pamir Atagündüz · 2021 · TURKISH JOURNAL OF BIOLOGY
97. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
    Shen Wang, Bo Liang, Weiqi Wang, Lin Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang, Xianzhu Xia · 2023 · Signal Transduction and Targeted Therapy
98. eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2
    Subhasis Mahari, Akanksha Roberts, Deepshikha Shahdeo, Sonu Gandhi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
99. Management and Treatment of COVID-19: The Chinese Experience
    Fujun Peng, Lei Tu, Yongshi Yang, Peng Hu, Runsheng Wang, Qinyong Hu, Feng Cao, Taijiao Jiang, Jinlyu Sun, Guogang Xu et al. · 2020 · Canadian Journal of Cardiology
100. COVID-19 Antibody Tests and Their Limitations
     Guoqiang Liu, James F. Rusling · 2021 · ACS Sensors